首页> 外文期刊>Experimental and clinical transplantation >Effect of Prediabetes on Allograft Survival and Evolution of New-Onset Diabetes After Transplant in Deceased-Donor Kidney Transplant Recipients During Long-Term Follow-Up
【24h】

Effect of Prediabetes on Allograft Survival and Evolution of New-Onset Diabetes After Transplant in Deceased-Donor Kidney Transplant Recipients During Long-Term Follow-Up

机译:长期随访期间,前驱糖尿病对死者肾脏移植受者移植后异体移植存活和新发糖尿病的影响

获取原文
       

摘要

Objectives: This study investigated the effect of prediabetes in long-term deceased-donor renal transplant recipients regarding graft survival, graft function, and evolution of new-onset diabetes after transplant compared with a control group of graft recipients with normal glucose tolerance test results. Materials and Methods: This was a follow-up trial of 187 deceased-donor renal transplant recipients. Based on oral glucose tolerance test results, the cohort was divided into groups A and B, comprising individuals with normal glucose metabolism (n = 130, 69.9%) and individuals with prediabetes (n = 56, 30.1%). Data are shown as means ± standard errors. Results: Both groups showed similar total transplant survival (116.8 ± 5.4 vs 114.5 ± 7.4 mo; P = .742) and transplant survival measured since oral glucose tolerance test (58.5 ± 1.4 vs 59.5 ± 1.9 mo; P = .990, Mantel-Cox P = .943). Univariate and multivariate Cox regression analyses showed no association of prediabetes with graft loss. Transplant function changes were similar between cohorts (-3 ± 1 vs -5 ± 2 mL/min/1.73 m 2 body surface area, using the Chronic Kidney Disease Epidemiology Collaboration formula; P = .538). At 5-year follow-up, recipients with prediabetes had higher hemoglobin A1c than controls (5.99% ± 0.10% vs 5.67% ± 0.04%; P = .002). Prediabetes was associated with a 4.5-fold increased hazard of new-onset diabetes after transplant ( P = .021). Conclusions: Prediabetes was associated with a 4.5-fold higher hazard ratio for new-onset diabetes after transplant but not with reduced graft function or survival.
机译:目的:本研究与糖耐量测试结果正常的对照组相比,研究了长期死亡的肾脏供体长期移植患者中前驱糖尿病对移植物存活,移植功能和新发糖尿病演变的影响。材料和方法:这是对187名死者肾移植受者的随访试验。根据口服葡萄糖耐量测试结果,该队列分为A组和B组,分别为葡萄糖代谢正常的患者(n = 130,69.9%)和糖尿病前期的患者(n = 56,30.1%)。数据显示为平均值±标准误差。结果:两组患者的总移植存活率相似(116.8±5.4 vs 114.5±7.4 mo; P = .742),自口服葡萄糖耐量试验以来测得的移植存活率(58.5±1.4 vs 59.5±1.9 mo; P = .990,Mantel- Cox P = .943)。单因素和多因素Cox回归分析显示,糖尿病前期与移植物丢失无关联。队列之间的移植功能变化相似(使用慢性肾脏病流行病学协作公式,P = 0.538,-3±1 vs -5±2 mL / min / 1.73 m 2体表面积)。在5年的随访中,糖尿病前期患者的血红蛋白A1c高于对照组(5.99%±0.10%对5.67%±0.04%; P = .002)。糖尿病前期与移植后新发糖尿病的风险增加了4.5倍相关(P = .021)。结论:糖尿病患者移植后新发糖尿病的危险比高4.5倍,但移植物功能或存活率降低却没有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号